PHARMPROTECH HOLDING ApS Financials, key figures and credit report
Gross profit - 767.2 kDKK FY 2025 -368.7% vs 2024
EBIT - 767.2 kDKK FY 2025 -368.7% vs 2024
Net debt 4 557.6 kDKK FY 2025 -1.2% vs 2024
Quick ratio 1.5 FY 2025 -2.5 vs 2024
Income statement (kDKK)
2021 | 2022 | 2023 | 2024 | 2025 | |
|---|---|---|---|---|---|
| Fiscal period length | 12 | 12 | 12 | 12 | 12 |
| Net sales | |||||
| Gross profit | -10.00 | -10.00 | -17.10 | - 163.69 | - 767.19 |
| Total depreciation | - 104.61 | - 104.61 | |||
| EBIT | - 114.61 | 94.61 | -17.10 | - 163.69 | - 767.19 |
| Other financial income | 272.88 | 343.47 | 462.37 | 1 001.60 | 384.50 |
| Other financial expenses | - 200.77 | - 103.27 | - 120.07 | - 348.92 | - 241.84 |
| Reduction non-current investment assets | - 100.00 | 100.00 | |||
| Net income from associates (fin.) | 1 411.27 | 5 216.79 | 4 940.18 | 5 500.78 | 4 248.13 |
| Pre-tax profit | 1 268.77 | 5 651.61 | 5 265.38 | 5 989.77 | 3 623.59 |
| Income taxes | 9.38 | -70.62 | -75.79 | - 111.85 | -28.42 |
| Net earnings | 1 278.15 | 5 580.99 | 5 189.59 | 5 877.92 | 3 595.18 |
Assets (kDKK)
2021 | 2022 | 2023 | 2024 | 2025 | |
|---|---|---|---|---|---|
| Intangible assets total | |||||
| Tangible assets total | |||||
| Holdings in group member companies | 13 516.98 | 17 390.84 | 21 035.60 | 22 078.48 | 36 637.41 |
| Investments total | 13 516.98 | 17 390.84 | 21 035.60 | 22 078.48 | 36 637.41 |
| Long term receivables total | |||||
| Inventories total | |||||
| Current amounts owed by group member comp. | 6 699.37 | 7 042.77 | 11 898.57 | 16 194.00 | 5 732.00 |
| Current other receivables | 761.59 | ||||
| Current deferred tax assets | 2 477.43 | 2 903.72 | 1 693.22 | 1 488.61 | 1 203.12 |
| Short term receivables total | 9 176.79 | 9 946.49 | 13 591.79 | 18 444.19 | 6 935.11 |
| Cash and bank deposits | 8.76 | 294.61 | 52.77 | 8.24 | 422.07 |
| Cash and cash equivalents | 8.76 | 294.61 | 52.77 | 8.24 | 422.07 |
| Balance sheet total (assets) | 22 702.53 | 27 631.95 | 34 680.16 | 40 530.92 | 43 994.60 |
Equity and liabilities (kDKK)
2021 | 2022 | 2023 | 2024 | 2025 | |
|---|---|---|---|---|---|
| Share capital | 125.00 | 125.00 | 125.00 | 125.00 | 125.00 |
| Shares repurchased | 57.20 | 58.90 | 61.00 | 67.50 | |
| Other reserves | 7 583.90 | 11 550.70 | 15 090.87 | 16 430.07 | 19 188.99 |
| Retained earnings | 9 021.38 | 6 332.74 | 8 314.65 | 12 104.05 | 15 155.55 |
| Profit of the financial year | 1 278.15 | 5 580.99 | 5 189.59 | 5 877.92 | 3 595.18 |
| Shareholders equity total | 18 065.64 | 23 589.43 | 28 779.02 | 34 598.04 | 38 132.22 |
| Non-current deferred tax liabilities | 634.11 | 1 709.03 | 1 401.93 | 1 270.54 | 819.53 |
| Non-current liabilities total | 634.11 | 1 709.03 | 1 401.93 | 1 270.54 | 819.53 |
| Current trade creditors | 6.00 | 6.00 | 6.00 | 6.00 | 6.00 |
| Current owed to group member | 3 641.36 | 1 521.23 | 4 322.55 | 4 622.00 | 4 979.70 |
| Short-term deferred tax liabilities | 355.34 | 806.26 | 167.08 | 34.34 | 57.15 |
| Other non-interest bearing current liabilities | 0.09 | 3.59 | |||
| Current liabilities total | 4 002.79 | 2 333.48 | 4 499.21 | 4 662.34 | 5 042.85 |
| Balance sheet total (liabilities) | 22 702.53 | 27 631.95 | 34 680.16 | 40 530.92 | 43 994.60 |
Secure checkout
Buy AI Credit Risk Report
Pay by card and the report is generated automatically and sent to your email. One-time payment – no subscription.
How it works
- 01 You pay €3 (incl. VAT) securely by card via Stripe.
- 02 You enter your email address in Stripe's payment window – the report is sent there.
- 03 The report is generated automatically and sent as a PDF within 30 minutes.
- 04 If generation should fail, you are not charged.
- 05 You receive the receipt by email once the report has been generated and completed.
Do you want to buy the AI Credit Risk Report (3 EUR / report)?
The report is sent to the email address you enter in Stripe's payment window. Please also check your spam folder. Questions? Write to info@creditreports.dk.
Page generated